BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33416451)

  • 1. New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans.
    Ferté L; Marino A; Battault S; Bultot L; Van Steenbergen A; Bol A; Cumps J; Ginion A; Koepsell H; Dumoutier L; Hue L; Horman S; Bertrand L; Beauloye C
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H838-H853. PubMed ID: 33416451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.
    Banerjee SK; McGaffin KR; Pastor-Soler NM; Ahmad F
    Cardiovasc Res; 2009 Oct; 84(1):111-8. PubMed ID: 19509029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.
    Kashiwagi Y; Nagoshi T; Yoshino T; Tanaka TD; Ito K; Harada T; Takahashi H; Ikegami M; Anzawa R; Yoshimura M
    PLoS One; 2015; 10(6):e0130605. PubMed ID: 26121582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2.
    Kanwal A; Singh SP; Grover P; Banerjee SK
    Anal Biochem; 2012 Oct; 429(1):70-5. PubMed ID: 22796500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.
    Balteau M; Tajeddine N; de Meester C; Ginion A; Des Rosiers C; Brady NR; Sommereyns C; Horman S; Vanoverschelde JL; Gailly P; Hue L; Bertrand L; Beauloye C
    Cardiovasc Res; 2011 Nov; 92(2):237-46. PubMed ID: 21859816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.
    Banerjee SK; Wang DW; Alzamora R; Huang XN; Pastor-Soler NM; Hallows KR; McGaffin KR; Ahmad F
    J Mol Cell Cardiol; 2010 Oct; 49(4):683-92. PubMed ID: 20600102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorption of glucose in mice as determined by positron emission tomography.
    Sala-Rabanal M; Ghezzi C; Hirayama BA; Kepe V; Liu J; Barrio JR; Wright EM
    J Physiol; 2018 Jul; 596(13):2473-2489. PubMed ID: 29707805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats.
    Nagata T; Fukazawa M; Honda K; Yata T; Kawai M; Yamane M; Murao N; Yamaguchi K; Kato M; Mitsui T; Suzuki Y; Ikeda S; Kawabe Y
    Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E414-23. PubMed ID: 23249697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phlorizin binding domains in sodium-glucose cotransporter family: SGLT1 as a unique model system.
    Raja M; Kinne RK
    Biochimie; 2015 Aug; 115():187-93. PubMed ID: 26086341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Na+-D-glucose cotransporter: no role in insulin-mediated glucose uptake.
    Kolka CM; Rattigan S; Richards SM; Barrett EJ; Clark MG
    Horm Metab Res; 2005 Nov; 37(11):657-61. PubMed ID: 16308832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of SGLT1 and SGLT2 inhibitors.
    Rieg T; Vallon V
    Diabetologia; 2018 Oct; 61(10):2079-2086. PubMed ID: 30132033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats.
    Yamaguchi K; Kato M; Suzuki M; Asanuma K; Aso Y; Ikeda S; Ishigai M
    Drug Metab Dispos; 2011 Oct; 39(10):1801-7. PubMed ID: 21712434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the intestinal sodium-coupled glucose transporter 1 (SGLT1) by extracts and polyphenols from apple reduces postprandial blood glucose levels in mice and humans.
    Schulze C; Bangert A; Kottra G; Geillinger KE; Schwanck B; Vollert H; Blaschek W; Daniel H
    Mol Nutr Food Res; 2014 Sep; 58(9):1795-808. PubMed ID: 25074384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
    Dominguez Rieg JA; Rieg T
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 2(Suppl 2):43-52. PubMed ID: 31081587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence method for measurement of glucose transport in kidney cells.
    Blodgett AB; Kothinti RK; Kamyshko I; Petering DH; Kumar S; Tabatabai NM
    Diabetes Technol Ther; 2011 Jul; 13(7):743-51. PubMed ID: 21510766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents.
    Du F; Hinke SA; Cavanaugh C; Polidori D; Wallace N; Kirchner T; Jennis M; Lang W; Kuo GH; Gaul MD; Lenhard J; Demarest K; Ajami NJ; Liang Y; Hornby PJ
    J Pharmacol Exp Ther; 2018 Jun; 365(3):676-687. PubMed ID: 29674332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts.
    Meng L; Uzui H; Guo H; Tada H
    Mol Med Rep; 2018 May; 17(5):6887-6892. PubMed ID: 29512713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of glucose metabolism, osmotic stress, and sodium-glucose cotransporter isoform-mediated transport on Na+/H+ exchanger isoform 3 activity in the renal proximal tubule.
    Pessoa TD; Campos LC; Carraro-Lacroix L; Girardi AC; Malnic G
    J Am Soc Nephrol; 2014 Sep; 25(9):2028-39. PubMed ID: 24652792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.